“Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma” has been added to your cart. View cart

Article: EXTENDED HALF-LIFE PRODUCTS: PROTECTION OR CONVENIENCE? CONVERTING TO EHL rFVIIIFc

€3.03

SKU: product-article-18511 Category: General

Description
Reviews (0)

Description

EXTENDED HALF-LIFE PRODUCTS: PROTECTION OR CONVENIENCE? CONVERTING TO EHL rFVIIIFc

Reviews

There are no reviews yet.

Be the first to review “Article: EXTENDED HALF-LIFE PRODUCTS: PROTECTION OR CONVENIENCE? CONVERTING TO EHL rFVIIIFc”

You must be logged in to post a review.

Top

Article: EXTENDED HALF-LIFE PRODUCTS: PROTECTION OR CONVENIENCE? CONVERTING TO EHL rFVIIIFc

Description

Reviews

Related products

Article: Highlights in digestive oncology

Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma

Article: Highlights in breast cancer

Article: Highlights in respiratory oncology